Product
89Zr-Oxine-RY_SW01
1 clinical trial
1 indication
Indication
systemic sclerosisClinical trial
Phase I Clinical Study of in Vivo Distribution and Metabolic Kinetic Characterization of 89Zr-Oxine-RY_SW01 Cell Injection for the Treatment of Systemic SclerosisStatus: Not yet recruiting, Estimated PCD: 2025-05-31